Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme Court to curtail litigation alleging its Roundup pesticide causes cancer.

Bayer’s Aspirina, the #1 pain relief option in Mexico per Bayer, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. Bayer noted that as the ...

Shares in Bayer rose after the company reported positive results from a clinical trial for an experimental stroke-preventing drug which had previously showed to be ineffective in another trial. The ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

Bayer (OTCPK:BAYRY) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its tyrosine kinase inhibitor Hyrnuo (sevabertinib) under the agency’s accelerated approval process ...

Bayer AG BAYRY reported third-quarter 2025 core earnings of 17 cents per American Depositary Receipt (ADR), which comfortably beat the Zacks Consensus Estimate of 13 cents per ADR. The company ...

Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...

Process intelligence is changing how businesses operate, from enterprise technology to the life science industry. By partnering with Celonis SE, a process intelligence and AI platform, Bayer AG has ...

A federal judge in San Francisco gave final approval to a $38 million class action settlement in a case against Bayer over investors’ claims that it didn’t conduct due diligence before making a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Bayer AG has reached agreements ...